Objective To compare two oral contraceptive pills, both containing 150 μg desogestrel, but
with either 20 μg (Mercilon®) or 30 μg (Marvelon®/Desolett®) ethinyl oestradiol (EE) …

Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …

The study reported herein is the primary efficacy and safety study conducted to support US
registration of an oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl …

During oral treatment with 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21
days followed by 0.030 mg (A) desogestrel (15 women) or placebo (B)(14 women) for 7 …

This study compares the contraceptive reliability, cycle control, and tolerability of two oral
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …

The clinical experience with a combined oral contraceptive (COC) containign 150 μg
desogestrel and 30 μg ethinylestradiol is reviewed. Fourteen clinical trials have been …

The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …

A multicenter trial was conducted in 267 centers in Italy to evaluate the efficacy, acceptability
and safety of a monophasic oral contraceptive containing 30 micrograms ethinyl estradiol …

Objective To compare the contraceptive efficacy, bleeding pattern, acceptability and safety of
desogestrel 75 μg/day (Cerazette®) as a progestogen-only formulation to levonorgestrel 30 …

The aim of the trial was to demonstrate the contraceptive efficacy of a new low dose oral
contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel and to observe …